Assessment of ocrelizumab impact on neurofilament levels in multiple sclerosis patients
, , , oraz
31 lip 2024
O artykule
Data publikacji: 31 lip 2024
Zakres stron: 245 - 254
Otrzymano: 11 kwi 2024
Przyjęty: 23 kwi 2024
DOI: https://doi.org/10.2478/rrlm-2024-0019
Słowa kluczowe
© 2024 Smaranda Maier et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Maier, Smaranda
Department of Neurology, Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu MuresRomania
Neurology 1 Clinic, Mures County Emergency Clinical HospitalTargu Mures, Romania
Huțanu, Adina
Department of Laboratory Medicine, Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu MuresRomania
Central Laboratory, Mures County Emergency Clinical HospitalTargu Mures, Romania
Center for Advanced Medical and Pharmaceutical Research, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu MuresRomania
Bărcuțean, Laura
Department of Neurology, Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu MuresRomania
Neurology 1 Clinic, Mures County Emergency Clinical HospitalTargu Mures, Romania
Sărmășan, Emanuela
Neurology 1 Clinic, Mures County Emergency Clinical HospitalTargu Mures, Romania
Bălașa, Rodica
Department of Neurology, Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu MuresRomania
Neurology 1 Clinic, Mures County Emergency Clinical HospitalTargu Mures, Romania